Jose E Abdenur

Dr. Jose E Abdenur


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
ASAshlee R. Stiles
Ashlee R. Stiles
MSMariella T. Simon
Mariella T. Simon
ASAlexander Stover
Alexander Stover
SEShaya Eftekharian
Shaya Eftekharian
NKNegar Khanlou
Negar Khanlou
JAJose E Abdenur
Jose E Abdenur

3 May 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
TETuany Eichwald
Tuany Eichwald
LSLucila de Bortoli da Silva
Lucila de Bortoli da Silva
APAnanda Christina Staats Pires
Ananda Christina Staats Pires
LNLaís Niero
Laís Niero
ESErick Schnorrenberger
Erick Schnorrenberger
ALAlexandra Latini
Alexandra Latini
Tetrahydrobiopterin (BH4) is an endogenous cofactor for some enzymatic conversions of essential biomolecules, including nitric oxide, and monoamine neurotransmitters, and for the metabolism of phenylalanine and lipid esters. Over the last decade, BH4 metabolism has emerged as a promising metabolic target for negatively modulating toxic pathways that may result in cell death. Strong preclinical evidence has shown that BH4 metabolism has multiple biological roles beyond its traditional cofactor activity. We have shown that BH4 supports essential pathways, e.g., to generate energy, to enhance the antioxidant resistance of cells against stressful conditions, and to protect from sustained inflammation, among others. Therefore, BH4 should not be understood solely as an enzyme cofactor, but should instead be depicted as a cytoprotective pathway that is finely regulated by the interaction of three different metabolic pathways, thus assuring specific intracellular concentrations. Here, we bring state-of-the-art information about the dependency of mitochondrial activity upon the availability of BH4, as well as the cytoprotective pathways that are enhanced after BH4 exposure. We also bring evidence about the potential use of BH4 as a new pharmacological option for diseases in which mitochondrial disfunction has been implicated, including chronic metabolic disorders, neurodegenerative diseases, and primary mitochondriopathies.

1 January 2019 in Molecular Genetics and Metabolism
Verified
Journal Article
Open access
MSMariella T. Simon
Mariella T. Simon
SEShaya S. Eftekharian
Shaya S. Eftekharian
ASAlexander E. Stover
Alexander E. Stover
AOAaron F. Osborne
Aaron F. Osborne
BBBruce H. Braffman
Bruce H. Braffman
JAJose E Abdenur
Jose E Abdenur
Primary mitochondrial complex I deficiency is the most common defect of the mitochondrial respiratory chain. It is caused by defects in structural components and assembly factors of this large protein complex. Mutations in the assembly factor NDUFAF5 are rare, with only five families reported to date. This study provides clinical, biochemical, molecular and functional data for four unrelated additional families, and three novel pathogenic variants. Three cases presented in infancy with lactic acidosis and classic Leigh syndrome. One patient, however, has a milder phenotype, with symptoms starting at 27 months and a protracted clinical course with improvement and relapsing episodes. She is homozygous for a previously reported mutation, p.Met279Arg and alive at 19 years with mild neurological involvement, normal lactate but abnormal urine organic acids. We found the same mutation in one of our severely affected patients in compound heterozygosity with a novel p.Lys52Thr mutation. Both patients with p.Met279Arg are of Taiwanese descent and had severe hyponatremia. Our third and fourth patients, both Caucasian, shared a common, newly described, missense mutation p.Lys109Asn which we show induces skipping of exon 3. Both Caucasian patients were compound heterozygotes, one with a previously reported Ashkenazi founder mutation while the other was negative for additional exonic variants. Whole genome sequencing followed by RNA studies revealed a novel deep intronic variant at position c.223-907A>C inducing an exonic splice enhancer. Our report adds significant new information to the mutational spectrum of NDUFAF5, further delineating the phenotypic heterogeneity of this mitochondrial defect.

1 May 2018 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
MBM. Boyer
M. Boyer
MSM. Sowa
M. Sowa
IMIvano Di Meo
Ivano Di Meo
SES. Eftekharian
S. Eftekharian
MSM.R. Steenari
M.R. Steenari
JAJose E Abdenur
Jose E Abdenur

1 January 2006 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
JAJose E Abdenur
Jose E Abdenur
NANico Abeling
Nico Abeling
NSNorma Specola
Norma Specola
LJLia Jorge
Lia Jorge
ASAndrea B. Schenone
Andrea B. Schenone
NCNestor A. Chamoles
Nestor A. Chamoles

1 August 2015 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
ASAshlee R. Stiles
Ashlee R. Stiles
SFSacha Ferdinandusse
Sacha Ferdinandusse
ABArnaud Besse
Arnaud Besse
VAVivek Appadurai
Vivek Appadurai
KLKaren B. Leydiker
Karen B. Leydiker
JAJose E Abdenur
Jose E Abdenur